Home
Conditions
Lymphoma, T-Cell

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Not Yet Recruiting

Go-CHOP in de Novo Intestinal T-cell Lymphoma Patients

NCT06701344

Conditions: Enteropathy Associated T Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma

NCT06671717

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Peking University, Institute of Hematolgoy, Beijing, Beijing, China

View Trial Details

Not Yet Recruiting

Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study

NCT06651203

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Selinexor, Anti-PD-1 Antibody Plus Golidocitinib in R/R NKTCL

NCT06573138

Conditions: Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma

NCT06548347

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

NCT05923502

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Large B Cell Lymphoma, +27 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides

NCT05205902

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas

NCT04520529

Conditions: Cutaneous Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)

NCT05455931

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: The Johns Hopkins University School of Medicine Baltimore, Maryland, United States

Washington University School of Medicine St Louis, Missouri, United States

Colombia University Medical Center New York, United States

Inova Dwight and Martha Schar Cancer Institute Fairfax, Virginia, United States

View all 19 locations

View Trial Details

Completed

Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)

NCT01657331

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Center for Lymphoid Malignancies at CUMC New York, United States

British Columbia Cancer Agency Vancouver, British Columbia, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Lymphoma, T-Cell

Lymphoma, T-Cell trial results

Related conditions